Collin M - Search Results

1

Inhibiting glycogen synthase kinase 3beta in sepsis.

Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala E, Louhelainen M, Foster SJ, Yaqoob MM, Thiemermann C. Dugo L, et al. Among authors: collin m. Novartis Found Symp. 2007;280:128-42; discussion 142-6, 160-4. Novartis Found Symp. 2007. PMID: 17380792

2

The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock.

Collin M, Thiemermann C. Collin M, et al. Eur J Pharmacol. 2003 Aug 29;476(3):257-8. doi: 10.1016/s0014-2999(03)02179-4. Eur J Pharmacol. 2003. PMID: 12969773

3

Endogenous ligands of PPAR-gamma reduce the liver injury in haemorrhagic shock.

Collin M, Abdelrahman M, Thiemermann C. Collin M, et al. Eur J Pharmacol. 2004 Feb 20;486(2):233-5. doi: 10.1016/j.ejphar.2003.12.032. Eur J Pharmacol. 2004. PMID: 14975712

4

Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin.

Collin M, Patel NS, Dugo L, Thiemermann C. Collin M, et al. Crit Care Med. 2004 Mar;32(3):826-31. doi: 10.1097/01.ccm.0000114821.25573.e7. Crit Care Med. 2004. PMID: 15090969

5

Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia.

Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, Thiemermann C. Abdelrahman M, et al. Among authors: collin m. Shock. 2004 Jul;22(1):63-9. doi: 10.1097/01.shk.00001276869.21260.9d. Shock. 2004. PMID: 15201704

6

Urocortin does not reduce the renal injury and dysfunction caused by experimental ischaemia/reperfusion.

Patel NS, Collin M, Thiemermann C. Patel NS, et al. Among authors: collin m. Eur J Pharmacol. 2004 Aug 2;496(1-3):175-80. doi: 10.1016/j.ejphar.2004.06.008. Eur J Pharmacol. 2004. PMID: 15288588

7

Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.

Collin M, Rossi A, Cuzzocrea S, Patel NS, Di Paola R, Hadley J, Collino M, Sautebin L, Thiemermann C. Collin M, et al. J Leukoc Biol. 2004 Nov;76(5):961-70. doi: 10.1189/jlb.0604338. Epub 2004 Aug 24. J Leukoc Biol. 2004. PMID: 15328337

8

15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria.

Dugo L, Collin M, Cuzzocrea S, Thiemermann C. Dugo L, et al. Among authors: collin m. Eur J Pharmacol. 2004 Sep 13;498(1-3):295-301. doi: 10.1016/j.ejphar.2004.07.074. Eur J Pharmacol. 2004. PMID: 15364008

9

The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock.

Abdelrahman M, Collin M, Thiemermann C. Abdelrahman M, et al. Among authors: collin m. Shock. 2004 Dec;22(6):555-61. doi: 10.1097/01.shk.0000144132.13900.24. Shock. 2004. PMID: 15545828

10

The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion.

Collino M, Patel NS, Lawrence KM, Collin M, Latchman DS, Yaqoob MM, Thiemermann C. Collino M, et al. Among authors: collin m. Kidney Int. 2005 Aug;68(2):529-36. doi: 10.1111/j.1523-1755.2005.00430.x. Kidney Int. 2005. PMID: 16014029 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters